2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Oral Nuvisertib (TP-3654) in Patients With MyelofibrosisHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosisRecruitingPhase 1 / Phase 22026-10-02NCT04176198
Study of Biomarker-Based Treatment of Acute Myeloid LeukemiaPreviously Untreated Relapsed Refractory Acute Myeloid LeukemiaRecruitingPhase 2 / Phase 32026-09-03NCT03013998